Post-earnings recap
Reported
Wed, Oct 26, 2011
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Thermo Fisher Scientific reported an EPS of $1.07, slightly beating expectations, but the lack of revenue figures and management commentary may have contributed to a significant stock decline of 9.15%. Investors may be concerned about the absence of guidance and insights from management, leading to uncertainty about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.07 | N/A | +0.09% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.